SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics Monthly Activity About

SEC Company Response from Apex Treasury Corp (APXT, APXTU, APXTW) (CIK 0002079253) (APXT) — Oct 1, 2025

Apex Treasury Corp (APXT, APXTU, APXTW) (CIK 0002079253)
Date: Oct. 1, 2025 · CIK: 0002079253 · Accession: 0001213900-25-094794

Financial Reporting Regulatory Compliance Capital Structure

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-289485

Referenced dates: September 5, 2025

Date
October 1, 2025
Author
Elliott Smith
Form
CORRESP
Company
Apex Treasury Corp (APXT, APXTU, APXTW) (CIK 0002079253)

Letter

Perkins Coie LLP

1155 Avenue of the Americas

22nd Floor

New York, NY 10036-2711

T. +1.212.262.6900

F. +1.212.977.1649

perkinscoie.com

October 1, 2025

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Real Estate & Construction

100 F Street NE

Washington, D.C. 20549

Attention: Gus Rodriguez

John Cannarella

Cheryl Brown

Kevin Dougherty

Re: Apex Treasury Corp

Registration Statement on Form S-1

Filed August 11, 2025

File No. 333-289485

Ladies and Gentlemen:

On behalf of our client, Apex Treasury Corporation, a Cayman Islands exempted company (the “Company”), we are writing to submit the Company’s responses to the comments of the staff of the Division of Corporation Finance of the United States Securities and Exchange Commission (the “Staff”) with respect to the above-referenced Registration Statement on Form S-1 (the “Registration Statement”), contained in the Staff’s letter dated September 5, 2025 (the “Comment Letter”).

The Company has filed via EDGAR Amendment No. 1 to the Registration Statement (“Amendment No. 1”), which reflects the Company’s responses to the comments received by the Staff and certain updated information. For ease of reference, each comment contained in the Comment Letter is printed below in bold and is followed by the Company’s response. All page references in the responses set forth below refer to page numbers in the Amendment No. 1. Capitalized terms used but not defined herein have the meanings set forth in the Amendment No. 1.

Registration Statement on Form S-1 filed August 11, 2025

Summary

The Offering

Conflict of Interest, page 43

1. We note your disclosure that pursuant to a letter agreement, your sponsor, officers and directors have agreed to waive their redemption rights with respect to their founder shares and public shares in connection with the completion of an initial business combination and shareholder vote to approve an amendment to your charter. Please disclose whether consideration (in cash or in other form of value) was provided in exchange for the agreement by these parties to waive redemption rights. Refer to Item 1603(a)(8) of Regulation S-K.

Response: The Company acknowledges the comment of the Staff and has revised the disclosure on pages 37, 44, 139, 164 and 175.

United States Securities and Exchange Commission

October 1, 2025

Risk Factors

We are an emerging growth company and a smaller reporting company within the meaning of

the Securities Act..., page 98

2. We note that you are an emerging growth company and a smaller reporting company. Please revise your risk factor to disclose that even if you no longer qualify as an emerging growth company, you may still be subject to reduced reporting requirements so long as you are a smaller reporting company.

Response: The Company acknowledges the comment of the Staff and has revised the disclosure on page 98.

Capitalization, page 110

3. You disclose an over-allotment option liability of $318,500 in the As Adjusted column on June 30, 2025. Please disclose the model and the assumptions used to estimate the over-allotment option liability at June 30, 2025.

Response: The Company acknowledges the comment of the Staff and has revised the disclosure on pages 108 and 109.

4. Please provide us with a roll-forward of your actual June 30, 2025 accumulated deficit of $18,774 to the as adjusted, accumulated deficit of $9,013,107.

Response: Respectfully, as requested, the roll-forward of the actual June 30, 2025 accumulated deficit to the as adjusted accumulated deficit is as follows:

Total Additional Paid in Capital at June 30:

Proceeds from Sale of IPO Units 249,997,500

Private Placement Proceeds 7,000,000

Shares Subject to Conversion (249,997,500 )

Underwriting Discount (upfront plus deferred) (15,000,000 )

Over-allotment Liability (318,500 )

Offering Expenses (700,000 )

APIC for the issuance of the founder shares 24,167

Total APIC at June 30: (8,994,333 )(a)

(a) Adjustment required to properly reclassify negative Additional Paid In Capital to $0.

Total Accumulated Deficit at June 30:

Actual Accumulated Deficit at June 30 (18,774 )

Reclassification of negative APIC to Accumulated Deficit (8,994,333 )

Total as adjusted accumulated deficit (9,013,107 )

* * *

United States Securities and Exchange Commission

October 1, 2025

Please do not hesitate to contact Elliott Smith at (212) 261-6847 of Perkins Coie LLP with any questions or comments regarding this letter.

Best regards,
/s/ Perkins Coie LLP

Show Raw Text
CORRESP
1
filename1.htm

  Perkins Coie LLP

1155 Avenue of the Americas

22nd Floor

New York, NY 10036-2711

  T. +1.212.262.6900

F. +1.212.977.1649

perkinscoie.com

October 1, 2025

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Real Estate & Construction

100 F Street NE

Washington, D.C. 20549

  Attention:
  Gus Rodriguez

  John Cannarella

  Cheryl Brown

  Kevin Dougherty

 Re: Apex Treasury Corp

Registration Statement on Form S-1

Filed August 11, 2025

File No. 333-289485

Ladies and Gentlemen:

On behalf of our client, Apex
Treasury Corporation, a Cayman Islands exempted company (the “Company”), we are writing to submit the Company’s
responses to the comments of the staff of the Division of Corporation Finance of the United States Securities and Exchange Commission
(the “Staff”) with respect to the above-referenced Registration Statement on Form S-1 (the “Registration Statement”),
contained in the Staff’s letter dated September 5, 2025 (the “Comment Letter”).

The Company has filed via
EDGAR Amendment No. 1 to the Registration Statement (“Amendment No. 1”), which reflects the Company’s responses
to the comments received by the Staff and certain updated information. For ease of reference, each comment contained in the Comment Letter
is printed below in bold and is followed by the Company’s response. All page references in the responses set forth below refer to
page numbers in the Amendment No. 1. Capitalized terms used but not defined herein have the meanings set forth in the Amendment No. 1.

Registration Statement on Form S-1 filed August
11, 2025

Summary

The Offering

Conflict of Interest, page 43

 1. We note your disclosure that pursuant to a letter agreement, your sponsor, officers and directors have
agreed to waive their redemption rights with respect to their founder shares and public shares in connection with the completion of an
initial business combination and shareholder vote to approve an amendment to your charter. Please disclose whether consideration (in cash
or in other form of value) was provided in exchange for the agreement by these parties to waive redemption rights. Refer to Item 1603(a)(8)
of Regulation S-K.

Response: The Company acknowledges
the comment of the Staff and has revised the disclosure on pages 37, 44, 139, 164 and 175.

United States Securities and Exchange Commission

October 1, 2025

Risk Factors

We are an emerging growth company and a smaller
reporting company within the meaning of

the Securities Act..., page 98

 2. We note that you are an emerging growth company and a smaller reporting company. Please revise your
risk factor to disclose that even if you no longer qualify as an emerging growth company, you may still be subject to reduced reporting
requirements so long as you are a smaller reporting company.

Response: The Company acknowledges
the comment of the Staff and has revised the disclosure on page 98.

Capitalization, page 110

 3. You disclose an over-allotment option liability of $318,500 in the As Adjusted column on June 30, 2025.
Please disclose the model and the assumptions used to estimate the over-allotment option liability at June 30, 2025.

Response: The Company acknowledges
the comment of the Staff and has revised the disclosure on pages 108 and 109.

 4. Please provide us with a roll-forward of your actual June 30, 2025 accumulated deficit of $18,774 to
the as adjusted, accumulated deficit of $9,013,107.

Response: Respectfully, as requested,
the roll-forward of the actual June 30, 2025 accumulated deficit to the as adjusted accumulated deficit is as follows:

    Total Additional Paid in Capital at June 30:

    Proceeds from Sale of IPO Units
      249,997,500

    Private Placement Proceeds
      7,000,000

    Shares Subject to Conversion
      (249,997,500 )

    Underwriting Discount (upfront plus deferred)
      (15,000,000 )

    Over-allotment Liability
      (318,500 )

    Offering Expenses
      (700,000 )

    APIC for the issuance of the founder shares
      24,167

    Total APIC at June 30:
      (8,994,333 )(a)

(a) Adjustment required to properly reclassify negative Additional Paid In Capital to $0.

    Total Accumulated Deficit at June 30:

    Actual Accumulated Deficit at June 30
      (18,774 )

    Reclassification of negative APIC to Accumulated Deficit
      (8,994,333 )

    Total as adjusted accumulated deficit
      (9,013,107 )

* * *

    2

United States Securities and Exchange Commission

October 1, 2025

Please do not hesitate to
contact Elliott Smith at (212) 261-6847 of Perkins Coie LLP with any questions or comments regarding this letter.

    Best regards,

    /s/ Perkins Coie LLP

    cc:
    Hugh Cochrane, Apex Treasury Corporation

    3